(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202506 | 202406 | % Var | 202506 | 202406 | % Var | 202503 | 202403 | % Var | |
| Sales | 7.57 | 27.22 | -72.19 | 7.57 | 27.22 | -72.19 | 122.28 | 148.39 | -17.60 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 | 0.27 | 248.15 |
| PBIDT | -2.68 | -2.47 | 8.50 | -2.68 | -2.47 | 8.50 | 1.91 | 1.87 | 2.14 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -2.68 | -2.47 | 8.50 | -2.68 | -2.47 | 8.50 | 1.91 | 1.87 | 2.14 |
| Depreciation | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 | 0.15 | -60.00 |
| PBT | -2.69 | -2.48 | 8.47 | -2.69 | -2.48 | 8.47 | 1.85 | 1.72 | 7.56 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.43 | 4.65 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| PAT | -2.69 | -2.48 | 8.47 | -2.69 | -2.48 | 8.47 | 1.40 | 1.29 | 8.53 |
| Equity | 120.00 | 120.00 | 0.00 | 120.00 | 120.00 | 0.00 | 120.00 | 120.00 | 0.00 |
| PBIDTM(%) | -35.40 | -9.07 | 290.15 | -35.40 | -9.07 | 290.15 | 1.56 | 1.26 | 23.95 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: